Editor - Qingdi Quentinn Li | National Institutes of Health | 25333

Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Qingdi Quentinn Li

Qingdi Quentinn Li
Q Quentin Li Research Scientist  National Institutes of Health, USA.
National Institutes of Health


Q. Quentin Li is a research scientist at the National Institutes of Health, and was an assistant professor at the Mary Babb Randolph Cancer Center, West Virginia University Robert C. Byrd Health Sciences Center. He was a guest (visiting) professor for six reputed universities in China. He obtained an M.D. from China and worked as dermatologist at Sun Yat-Sen University School of Medicine. He also received his M.S. in microbiology & immunology and Ph.D. in pharmacology & experimental therapeutics from the University of Maryland School of Medicine, with postdoctoral training in molecular and cell biology of cancer in Medical Oncology Branch (formerly Medicine Branch) of the Center for Cancer Research at the National Cancer Institute. He is a member of the American Association for Cancer Research. He served as principal investigator on several grants funded by the National Institutes of Health and a pharmaceutical company. He was elected to Who’s Who in Medicine & Healthcare, Who’s Who in Science & Engineering, Who’s Who in America, and Who’s Who in the World in 2002 and 2003. He serves on the editorial board of 25 journals and is a reviewer for 64 scientific journals and a research & development foundation. He has authored over 110 peer-reviewed research articles and reviews and presented more than 70 papers at national and international scientific conferences & meetings.

Research Interest

Cellular metabolism, Cancer epigenetics, Cancer chemotherapy & epigenetic therapy, Molecular and cell biology of cancer, Photoimmunotherapy, Oncopharmacology, New antitumor drug research & development, Natural products as novel anticancer agents, Apoptosis & cell cycle control in cancer cells, DNA repair and platinum drug resistance in carcinomas, Identification of biomarkers & epigenetic markers for diagnosis & treatment of carcinomas, Epigenetic regulation of gene expression in T cells & tumor cells.